Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan
- Resource Type
- Article
- Source
- In
Neoplasia February 2022 24(2):133-144 - Subject
- Language
- ISSN
- 1476-5586